ArticlePloS one2026

Identifying potential inhibitors for wild-type EGFR tyrosine kinase through a cross-talk pathway strategy and an in-silico drug repurposing method.

Dorra Abdelmalek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.